Glycobiology and protein degradation

GlycoEra AG is a biotechnology company building a high-value pipeline of medicines in precision immunology based on deep expertise in glycobiology and protein degradation. GlycoEras innovative CustomGlycan platform enables the design, engineering, and development of novel biologics for a broad range of indications. GlycoEra is advancing a range of assets toward human clinical studies.